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Identiﬁcation of translationally controlled tumor protein in
promotion of DNA homologous recombination repair in
cancer cells by afﬁnity proteomics
Y Li1,6, H Sun1,6, C Zhang2,6, J Liu1, H Zhang1, F Fan1, RA Everley3, X Ning1, Y Sun1, J Hu1, J Liu2, J Zhang2, W Ye2, X Qiu2, S Dai4, B Liu4,
H Xu5, S Fu1, SP Gygi3 and C Zhou1
Translationally controlled tumor protein (TCTP) has been implicated in the regulation of apoptosis, DNA repair and drug resistance.
However, the underlying molecular mechanisms are poorly deﬁned. To better understand the molecular mechanisms underlying
TCTP involved in cellular processes, we performed an afﬁnity puriﬁcation-based proteomic proﬁling to identify proteins interacting
with TCTP in human cervical cancer HeLa cells. We found that a group of proteins involved in DNA repair are enriched in the
potential TCTP interactome. Silencing TCTP by short hairpin RNA in breast carcinoma MCF-7 cells leads to the declined repair
efﬁciency for DNA double-strand breaks on the GFP-Pem1 reporter gene by homologous recombination, the persistent activation
and the prolonged retention of γH2AX and Rad51 foci following ionizing radiation. Reciprocal immunoprecipitations indicated that
TCTP forms complexes with Rad51 in vivo, and the stability maintenance of Rad51 requires TCTP in MCF-7 cells under normal cell
culture conditions. Moreover, inactivation of TCTP by sertraline treatment enhances UVC irradiation-induced apoptosis in MCF-7
cells, and causes sensitization to DNA-damaging drug etoposide and DNA repair inhibitor olaparib. Thus, we have identiﬁed an
important role of TCTP in promoting DNA double-stand break repair via facilitating DNA homologous recombination processes and
highlighted the great potential of TCTP as a drug target to enhance conventional chemotherapy for cancer patients with high levels
of TCTP expression.
Oncogene (2017) 36, 6839–6849; doi:10.1038/onc.2017.289; published online 28 August 2017
INTRODUCTION
Genomes of all organisms must endure constant DNA damage
challenges that arise from endogenous DNA replication errors and
environmental insults including chemical carcinogens, viral infec-
tion, ionizing radiation (IR) and ultraviolet (UV) irradiation. To
combat these genotoxic stresses and maintain genome stability,
cells have evolved a signaling cascade termed DNA damage
response along with a variety of DNA repair processes dedicated
to counteracting various types of DNA damage lesions.1,2 DNA
damage response senses different types of DNA damage and
coordinates various cellular responses including activation of
transcription, cell cycle arrest, apoptosis and initiation of DNA
repair processes.3 DNA damage lesions caused by genotoxic
exposure include base modiﬁcations, interstrand crossing, single-
strand breaks and double-strand breaks. Of these, double-strand
breaks are the most severe DNA damage lesions, and they are
repaired by either non-homologous end joining (NHEJ) or
homologous recombination (HR) or both repair pathways.4 NHEJ
is a template free, and thus error prone, process that occurs
primarily in the G1 phase of cell cycle. DNA-PKcs (DNA-dependent
protein kinase, catalytic subunits), Ku70/Ku80, LIG4/ERCC4, LIG3,
LIG15–7 and so on, are the major components of NHEJ and its
alternative pathways. By contrast, HR requires a homologous DNA
sequence as a template, which is an error-free repair process that
mainly occurs in the S and G2–M phases.8 The key participants of
HR repair processes include MRE11-Rad50-NBS1 complex, ATM,
ATR, H2AX, RPA1, CtIP, BRCA1, BRCA2, Rad51, and its paralogs such
as Rad51B, Rad51C9–14 and so on. Failure of repairing those DNA
damage lesions and/or defects of DNA damage response signaling
and repair machinery often lead to genome instability including
increased gene mutations, chromosome rearrangements as well
as gain or loss of entire chromosomes, which are perhaps the
main culprit of human abnormal development, immunodeﬁciency
diseases and even tumorigenesis.
Translationally controlled tumor protein (TCTP, also called TPT1,
p23 or fortilin) is an evolutionary conserved small protein that
does not share signiﬁcant homology with any known proteins or
domains.11,15–17 It has been demonstrated TCTP involves in many
cellular processes. For example, TCTP was upregulated in response
to oxidative stress, heat shock and DNA damage.15,18,19 Further-
more, TCTP also stimulates cell survival by interacting with
antiapoptotic Bcl-xL and suppressing Bax-mediated proapoptotic
pathways.20,21 Several recent studies have shown that TCTP
participates in HR repair via association with ATM22 and in NHEJ
repair processes through its interaction with DNA-PKcs.19 In
addition, TCTP was shown to promote the ubiquitin-mediated
degradation of TP53,23,24 a tumor suppressor that plays a critical
role in orchestrating activation of cell cycle checkpoints,
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subsequent DNA repair processes and induction of apoptosis and
senescence.25,26
To better understand the molecular mechanisms underlying
TCTP involved in cellular processes, we used an immuno-
precipitation-based proteomic approach to identify the proteins
interacting with TCTP in human cervical cancer HeLa cells. We
found that a group of proteins involved in HR repair were enriched
in the TCTP interactome. We further demonstrated that Rad51, a
critical player in HR repair, is associated with TCTP, and a high level
of TCTP is required for efﬁcient HR repair in breast carcinoma
MCF-7 cells and for the stability maintenance of Rad51 in cells
under normal conditions. We also provided evidence that the
chemical inactivation of TCTP can sensitize cancer cells to DNA-
damaging agents.
RESULTS
Identiﬁcation of TCTP interactome in HeLa cells
To better understand how TCTP participates in various cellular
processes, we aimed to identify proteins interacting with TCTP in
human cells. We established a HeLa cell line (with a low level of
endogenous TCTP expression) stably expressing 3 × Flag-TCTP
driven by mammalian expression vector pcDNA3.1. Whole-cell
lysates were prepared from the 3 × Flag-TCTP-expressing cells or
control cells transformed with an empty vector. M2 antibodies
against Flag peptide were used for immunoprecipitation in above
cell lysates. The resulting bound proteins were resolved on 15%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE) gels, stained with Coomassie blue and each lane in the gel
was cut into six slices. Peptides were generated via in-gel trypsin
digestion and subjected to liquid chromatography tandem-mass
spectrometry (LC-MS/MS). An outline of our proﬁling approach is
shown in Figures 1a–c. By comparison with proteins identiﬁed in
the control immunoprecipitation (IP), we removed many obvious
contaminated proteins including keratin and most abundant
nonspeciﬁc binding proteins such as ribosomal proteins and
method-biased proteins binding to magnetic protein A beads.
Eventually, a total of 145 candidates potentially interacting with
TCTP in HeLa cells were obtained (Supplementary Table S1).
TCTP involves in DNA damage signaling and repair
We submitted these candidate proteins to PANTHER biological
process tool for gene ontology analysis.27 We found that apoptosis
(4%), ubiquitination (7%), response to stimuli (5%) and so on are
the major functional categories among these TCTP-interacting
candidates (Figure 2a). Most strikingly, a group of proteins under
the DNA replication and repair category were signiﬁcantly
enriched (10%) in the TCTP potential interactome (Figure 2a).
These proteins including RAD51B, a key player in HR repair; BRAT1,
a binding partner of BRCA1; BCCIP, a protein associating with
BRCA2; MRE11 and NBS1, components of MRE11-Rad50-NBS1 DNA
damage sensing complex; PIKK kinase ATR and DNA-PKcs, and so
on, are well known for their roles in HR- and NHEJ-mediated
double-strand DNA repair (Figure 2b). We also used GeneMANIA
program to identify networks among these DNA repair-related
candidates,28 and discovered several important DNA repair
modules such as HR repair, nucleotide excision repair, replication
factor C (RFC), COP9/signalosome/CSN-Cul4A-DDB and NHEJ
(Figures 2c–g); these well-deﬁned functional modules are crucial
for repair of DNA double-strand breaks and ultraviolet irradiation-
caused photoproducts. To further verify the link between TCTP
and DNA repair pathway, we treated HeLa cells with 300 ng/ml
neocarzinostatin (NCS, a radiomimetic drug causing DNA double-
strand breaks), harvested the treated cells at various time points
post NCS withdrawl from the medium and determined the
endogenous TCTP protein level by western blot. We found that
the TCTP level transiently increased upon NCS treatment, its level
peaked at 2 h time point post NCS treatment and gradually
dropped back to its original level (Supplementary Figure S1),
consistent with previous ﬁndings that DNA-damaging agents
cisplatin and etoposide are able to increase TCTP stability.11,29
Furthermore, immunostaining of 3 × Flag-TCTP in NCS-treated
cells (at 2 h time point post recovery) indicated that TCTP is a
predominantly cytoplasmic protein. Following NCS treatment,
there was a slight increase of overall signal of 3 × Flag-TCTP in
cells, but neither prominent nuclear relocalization of TCTP nor
nuclear TCTP foci formation was observed, except that some
cytoplasmic foci of TCTP occurred in both untreated and NCS-
treated cells independent of DNA damage (Supplementary
Figure S2a). Subcellular fractionation experiments revealed that
there is a weak signal of 3 × Flag-TCTP appeared in the nuclear
fraction at 2 h time point post NCS treatment (Supplementary
Figure S2b), which is consistent with a previous ﬁnding reported
by Zhang et al.19 Therefore, despite that TCTP responds to DNA
damage by a small increase of its abundance, it is more likely for
TCTP to involve in the DNA repair process as a regulatory player
rather than as a candidate repair enzyme accumulated on the sites
of DNA damage. The fact of no nuclear TCTP foci formation upon
DNA damage has further strengthened our above assumption.
Deﬁciency of TCTP impairs HR repair efﬁciency in cancer cells
Given the fact that a group of HR proteins occurred in our TCTP
interactome, we would like to determine whether TCTP involves in
the HR repair of DNA double-strand breaks. In this regard, we
worked on the breast carcinoma MCF-7 cells because of a high
level of endogenous TCTP expression in these cells. We integrated
GFP-PEM1 HR reporter gene cassettes into MCF-7 cells with TCTP
silenced by short hairpin RNA (shRNA) (hereafter referred to as
shTCTP-1, for western blot conﬁrmation of TCTP-knockdown cell
lines, see Supplementary Figure S3) or with a control shRNA
against ﬁreﬂy luciferase mRNA (hereafter referred to as shFF2), and
expressed restriction enzyme I-Sce I in the two cell lines by
transient plasmid transfection. Upon I-Sce I cleavage on the GFP-
Pem1 gene, the HR-mediated gene conversion will reconstitute
the full ﬂuorescent GFP gene30 (for detailed repair processes see
Supplementary Figure S4). Thus, we measured HR efﬁciency by
counting GFP-positive cells upon I-Sce I induction. At 24 h time
point after induction of I-Sce I, the average percentage of GFP-
positive cells in shFF2 or shTCTP-1 is 3.24 ± 0.06% and
0.64 ± 0.39%, respectively, and at 48 h time point post induction,
the percentage is increased to 4.99 ± 1.21% and 1.06 ± 0.30%,
respectively (Figures 3a–c). Obviously, there are fewer GFP cells in
shTCTP-1 cells compared with shFF2 cells at both 24 and 48 h time
points after I-Sce I induction (Po0.01, at 48 h). The lower
percentage of GFP-positive cells in the TCTP silencing cells
suggested that TCTP is required for efﬁcient HR repair in MCF-7
cells. To conﬁrm our observed changes of HR repair efﬁciency are
related to the TCTP expression level, not an effect of shRNA off-
target, we ectopically overexpressed shRNA-resistant TCTP in the
above shTCTP-1 cells (for the exact mutation sites of TCTP shRNA-
resistant gene see Materials and methods section). We found that
the percentages of GFP-positive cells in this rescued cell line are
similar to the shFF2 cells at both 24 and 48 h post I-Sce I induction
while the GFP-positive cells remain low in the empty vector-
transformed shTCTP-1 cells, indicating that the improved HR repair
is due to the restoration of high level expression of TCTP in the
TCTP-knockdown cells (Figures 3d and e).
Furthermore, we used immunostaining to assess the foci
formation of γH2AX and Rad51, two key markers for DNA damage
signaling and HR repair processes, in both shFF2 and shTCTP-1
cells irradiated with 10 Gy of γ-ray. At 2 h time point post IR
irradiation, the average foci number of Rad51 per shFF2 and
shTCTP-1 cell was 23.43 ± 10.15 and 22.73 ± 7.05, respectively.
After 12 h of recovery, the foci number of Rad51 in shFF2 cells
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dropped to 9.98 ± 2.90 (Figures 3f and g). By contrast, the number
and signal intensity of Rad51 foci in shTCTP-1 cells remained high
(20.64 ± 6.37) in comparison with shFF2 cells (Po0.01). In
addition, the foci formation of γH2AX behaved in a manner
similar to Rad51 foci (Figures 3h and i). Therefore, the persistent
activation of γH2AX and prolonged retention of Rad51 foci in
shTCTP-1 cells suggested that the efﬁciency of HR repair is
impaired upon TCTP silencing.
Association of Rad51 with TCTP in vivo and decreased stability of
Rad51 upon TCTP knockdown
How TCTP affects HR repair in MCF-7 cells is unclear; we checked
the interaction between TCTP and a couple of candidates such as
Rad51, Mre11 and BRAT1 from our screen by antibody-mediated
reciprocal immunoprecipitation in MCF-7 cells. The reciprocal IP
results indeed conﬁrm the association of Rad51 with TCTP
(Figure 4a). However, when we mixed GST-Rad51 protein with
6xHis-TCTP protein puriﬁed from transformed Escherichia coli
expressing Rad51 or TCTP fusion protein and performed GST pull-
down assay, we failed to observe the obvious direct binding
activity between each other, except that some weak nonspeciﬁc
binding signal related to the glutathione magnetic beads
(Figure 4b). Thus, we conclude that Rad51 might be indirectly
associated with TCTP in MCF-7 cells. Several previous studies
indicated that TCTP may regulate the protein stability of TP53 and
MDM2.23 Therefore, we checked the half-life of Rad51 protein, a
key player in HR repair processes, in MCF-7 cells with shTCTP-1 or
shFF2 expression. We treated these cells with 50 μg/ml of
cycloheximide (CHX), harvested at various time points and
determined TCTP protein level by western blotting. We found
that the average half-life of Rad51 in shFF2 cells is 45.3 ± 7.5 min,
whereas the average half-life of Rad51 in shTCTP-1 cells decreases
to 30.2 ± 6.3 min (Po0.05) (Figures 4c and d). The decreased half-
life of Rad51 indicates that Rad51 becomes less stable upon
knockdown of TCTP. As a result, the short half-life of Rad51 may
lead to impaired HR repair capacity in TCTP-deﬁcient cells.
However, following 10 Gy of IR, the Rad51 protein was stabilized
(Figure 4c, lower panel). Interestingly, this kind of stabilization
seems out of the TCTP control. Taken together, our data
suggested that a high level of TCTP is required for maintaining
the stability of Rad51 in MCF-7 cells.
Inactivation of TCTP by sertraline causes enhanced apoptosis
induced by DNA damage and increased sensitization to etoposide
and olaparib
TCTP has been implicated in the regulation of apoptosis,15 and a
number of chemical compounds such as antimalaria drug
dihydroartemisinin, antihistaminic agents and antidepressant drug
sertraline have been shown to be able to inhibit the expression of
TCTP in human and rodent cells and tissues.31–33 Therefore, we
want to determine whether inactivation of TCTP by sertraline
could sensitize MCF-7 cells to DNA-damaging agents' treatment.
We cultured MCF-7 cells in the presence of sertraline and
determined the optimal sertraline using a concentration of
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Figure 1. Proteomic identiﬁcation of TCTP interactome by immunoprecipitation (IP). (a) Schematic of the workﬂow of proﬁling of TCTP-
interacting proteins by IP combined with LC-MS/MS. Cell lysates were prepared from HeLa cells stably expressing 3 × Flag-TCTP or control cells
transformed with the empty vector. The M2 antibody-coupled magnetic beads were used for IP. The resulting bound proteins were resolved
on a 15% SDS–PAGE gel, the gel was stained with Coomassie blue and cut into slices. Peptides were extracted from in-gel trypsin digestion
and subjected to LC-MS/MS. (b) Western blot (WB) veriﬁcation of 3 × Flag-TCTP overexpression in HeLa cells. M2 antibody was used at 1:1000
of dilution, and GAPDH was as a loading control. (c) The efﬁciency of anti-Flag antibody-mediated TCTP IP. M2 antibody was used for both IP
and WB. Bound proteins were resolved on 15% SDS–PAGE gels. IgG-L and IgG-H are the light and heavy chains of M2 antibody.
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2.5 μM by cell viability assay (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay, data not shown). Under such
a concentration, the cultured cells display both normal morphol-
ogy and proliferation, whereas the TCTP protein level in the
treated cells decreases signiﬁcantly after 24 h of sertraline
treatment (Figure 5a). Moreover, at 24 h time point following
2.5 μM sertraline treatment, we subjected the treated MCF-7 cells
to 20 J/m2 UVC irradiation. After 24 h of recovery, the cells were
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Figure 2. Gene ontology (GO) analysis of potential TCTP interactome. (a) Classiﬁcation of biological processes of TCTP interactome by
PANTHER Classiﬁcation System. A total of 145 candidates were analyzed. (b) A group of proteins involving in DNA replication and repair are
enriched in the TCTP interactome. (c–g) Network modeling of candidates in (b) was analyzed by using GeneMANIA program, and the selected
functional modules with at least more than two identiﬁed candidates are shown as follows: (c) DNA HR repair module; (d) nucleotide excision
repair (NER) module; (e) replication factor C (RFC) module; (f) CSN-DDB module; (g) NHEJ module. In each module, solid lines indicate bilateral
interactions, proteins identiﬁed in our screen are marked in blue and other related proteins are in green.
Figure 3. Knockdown of TCTP in MCF-7 cells impairs the HR repair efﬁciency. (a and b) shFF2 and shTCTP-1 cells integrated with GFP-PEM1
cassettes were transiently co-transfected with I-Sce I and orange ﬂuorescence protein (OFP) expression vectors. GFP-positive cells were
observed under ﬂuorescence microscopy and measured by ﬂow cytometry at the indicated time points following I-Sce I induction. The
representative images of GFP-expressing cells in the two cell lines under ﬂuorescence microscopy with magniﬁcation of ×100 are shown in
(a). The representative ﬂow cytometry data are shown in (b). (c) The quantitative summary of ﬂow cytometry data. Data are presented as
mean± s.d. from at least three independent I-Sce I induction experiments and normalized to OFP-expressing cells for transfection efﬁciency
control. An error bar represents s.d. **Po0.01 indicates a signiﬁcant difference by Student's t-test. (d) Ectopic expression of shRNA-resistant
TCTP in TCTP-knockdown cells restores HR repair efﬁciency. pcDNA3.1(− ) 3 × Flag-TCTP-shRNA-resistant or the empty vectors were transfected
into shTCTP-1 cells integrated with GFP-PEM1 reporter gene. Stable expression cell lines were established after 200 μg/ml hygromycin B
selection. The average GFP-positive cells were counted by ﬂuorescence-assisted cell sorting (FACS) after the indicated times of I-Sce I
induction in the shRNA-resistant TCTP expression or empty vector control cells. **Po0.01 indicates a signiﬁcant difference by Student's t-test.
(e) Overexpression conﬁrmation of 3 × Flag-TCTP-shRNA resistant in MCF-7 shTCTP-1 cells by western blotting. (f and h) Knockdown of TCTP
prolonged the retention time of the foci of endogenous Rad51 and γH2AX. shFF2 and shTCTP-1 cells were irradiated with 10 Gy of γ-ray, and
recovered for the indicated times; cells were ﬁxed, permeabilized and processed for immunoﬂuorescence staining using antibodies against
Rad51 and γH2AX. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). The representative foci formation images at
indicated time points were shown in (f) and (h) ( ×1000). (g and i) Graphs in (g) and (i) represent quantitative summaries of Rad51 and γH2AX
foci, respectively. A total of 100 cells were counted for foci formation, the average foci number per cell was determined from at least three
independent IR experiments and data are presented as mean± s.d. Error bars represent s.d. **Po0.01 indicates a signiﬁcant difference by
Student's t-test.
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submitted to Annexin V-mediated ﬂuorescence-assisted cell
sorting. We found that there were more apoptotic cells in
sertraline-treated cells upon UVC irradiation (9.05 ± 0.36%) than
the cells without sertraline treatment (4.54 ± 0.32%, Po0.001)
(Figures 5b and c). Apoptosis is a common consequence induced
by extensive DNA damage from endogenous repair defects and/or
exogenous insults. Therefore, to demonstrate that the enhanced
apoptosis by sertraline treatment upon UV irradiation is relevant
to DNA repair impairment caused by inactivation of TCTP, we
examined whether sertraline could have synergistic effects on the
colony formation ability of MCF-7 cells exposed to the DNA-
damaging drug etoposide. Cells were treated with a single dose of
0.5 μM etoposide for 1 h on day 1, and then cultured in fresh
medium containing 2.5 μM sertraline for 7 days. The average
cologenic survival rate in the group of etoposide combined with
sertraline treatment was signiﬁcantly decreased compared with
etoposide treatment alone (13.1 ± 5.7% vs 35.5 ± 7.28%, Po0.05)
(Figures 5d and e), indicating sertraline treatment can sensitize
cancer cells to DNA-damaging drugs. To further prove the
relevance of sertraline treatment to DNA repair capacity, we
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tested whether sertraline could enhance the growth inhibition of
olaparib,34 a speciﬁc inhibitor for poly (ADP-ribose) polymerase 1
and 2, which prevent the formation of DNA double-strand
breaks,35,36 on MCF-7 cells in another setting of cologenic assays.
As shown in Figure 5f, sertraline treatment indeed greatly
sensitized MCF-7 cells to olaparib inhibition by a little more than
twofold increase of olaparib sensitivity. Furthermore, we examined
the endogenously arising γH2AX foci formation in the cells from
the cologenic assay because poly (ADP-ribose) polymerase
inhibitors can induce spontaneous double-strand breaks and
γH2AX foci formation.36 Compared with olaparib treatment alone,
the treatment of sertraline in combination with olaparib greatly
increased the mean number of endogenously arising γH2AX foci
per positive nucleus (from 4.54 ± 2.75 to 10.62 ± 3.98, Po0.05)
(Figure 5g ) and the average percentage of foci-positive cells (from
7.5 to 36.3%) (Figure 5h), indicating that sertraline treatment
indeed can exacerbate the DNA double-strand breaks triggered by
olaparib.
Finally, we examined the cytotoxicity kinetics of etoposide
treatment on MCF-7 cells upon knockdown of endogenous TCTP
by measuring cell survival and proliferation; we found that
knockdown of TCTP also led to the enhanced growth inhibition
of etoposide, in particular, at the high dose exposure of etoposide
compared with shFF2 control cells, whereas the reintroduction of
a Flag-tagged shRNA-resistant TCTP in the TCTP-knockdown cell
line almost restored its etoposide resistance to a level similar to
that displayed in the shFF2 cell line (Supplementary Figure S5).
Thus, the DNA damage sensitization caused by knockdown of TCTP is
in good agreement with what we have observed in the inactivation
by sertraline treatment. Taken together, our data indicate that there
is an intrinsic DNA repair defect underlying the inactivation of TCTP
by sertraline and uphold the great potential for TCTP as a new
therapeutic target for cancer targeting therapy in the clinic.
DISCUSSION
To determine the composition of highly dynamic protein
complexes in cells is a great challenge. Afﬁnity puriﬁcation
coupled with comparative and/or quantitative proteomics has
been proven a powerful approach to identify protein interac-
tion networks at the proteome level.37–39 Based on this strategy,
we discovered 145 proteins (TCTP itself not included) with the
potential of interacting with TCTP in HeLa cells. A close
examination found only a few known TCTP interactors such as
DNA-PKcs and histone family members appear in our list,19
whereas numerous other TCTP-interacting proteins including
ATM, MDM2, Mcl-1 (myeloid cell leukemia-1), Bcl-xL, PLK1,
tubulin, Hsp27 and Na-K-ATPase17,19,20,40–43 are missing from
our list. We consider the following reasons may account for
such a discrepancy between our TCTP interactome and previous
ﬁndings. First, some TCTP protein complexes may be only
formed and stabilized under a given circumstance such as
apoptosis or genotoxic stress, whereas our afﬁnity puriﬁcation
was performed in cells cultured under normal conditions.
Second, low abundance and/or low stoichiometry of certain
interacting proteins may impede them to be identiﬁed during
mass spectrometry. Third, the dynamic nature of the association
of protein kinases such as PLK1 and ATM with TCTP may cause
the failure of capturing these transient interactors by
immunoprecipitation.
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the association of Rad51 with TCTP in cells. One microgram of antibodies against Rad51 or TCTP were used for each reciprocal
immunoprecipitation in a total of 1 mg of MCF-7 cell lysates, and the precipitated proteins were resolved on SDS–PAGE gel and probed with
indicated antibodies. (b) No direct binding activity detected between puriﬁed Rad51 and TCTP. GST-Rad51 and 6×His-TCTP proteins were
puriﬁed from expression vector-transformed BL21 E. coli by using glutathione or Ni-NTA magnetic beads, 20 μg of each protein were mixed
together and subjected to GST pull down, proteins were resolved on SDS–PAGE gel and stained with Coomassie blue. (c) The representative
western blot images of Rad51 protein stability. TCTP knockdown of MCF-7 cells (shTCTP-1) or control cells (shFF2) at log phase were seeded
into 6 cm plates, after one day of culture, 50 μg/ml of CHX was added into each plates (for DNA damage exposure, cells were irradiated with
10 Gy of IR before CHX treatment) and cells were harvested at the indicated time points. A total of 40 μg cell lysate of each sample were
loaded and resolved on 12% SDS–PAGE gels, and an antibody against Rad51 was used for probing the endogenous Rad51. (d) The half-life of
Rad51 in TCTP-knockdown cells is decreased. The signal intensity of Rad51 in (c) was determined by densitometry in comparison with the
signal at time zero without CHX treatment, and normalized to GAPDH. The half-life of Rad51 was calculated based on at least three
independent CHX treatments and plotted in (d), and data are presented as mean± s.d. (min). An error bar represents s.d. *Po0.05 indicates a
signiﬁcant difference by Student's t-test.
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presence of 2.5 μM sertraline for 7 days. Representative cologenic assay images were shown in (d) and the average number of colonies (⩾ 50
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ﬂuorescence microscopy, the mean number of foci per positive nucleus and the average percentage of γH2AX-positive cells of each treatment
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On the other hand, our TCTP afﬁnity puriﬁcation proﬁling may
have revealed many more new potential TCTP interactors. For
example, MRE11 and NBS1, components of MRE11-Rad50-NBS1
complex for DNA damage sensing and activation of ATM kinase,
were identiﬁed as candidates associated with TCTP. In addition to
DNA damage response signaling, proteins involved in double-
strand break repair such as BRCA1-interacting protein BRAT144,45
and BRCA2-associated protein BCCIP46 showed up in our TCTP
interactome, hinting the potential role of TCTP in the maintenance
of genome stability in HeLa cells. In fact, TCTP has been implicated
in both NHEJ and HR repair.19,22 The nuclear translocation of Ku70
and Ku80, two crucial players of NHEJ, requires a certain level of
TCTP following IR in human skin AG1522 cells.19 ATM, a key
regulator for HR repair, is also known for its interaction with TCTP
in the control of genome stability and organ development of
Drosophila.22 Moreover, a number of TCTP-associated proteins
identiﬁed in our proﬁling, including RAD51B, ATR, MRE11, NBS1,
BRAT1, BCCIP, DNA-PKcs and LIG3, are more or less involved in
either HR or NHEJ, or even both pathways. One fact that needs to
be pointed out is that we failed to observe the direct binding
activity between GST-Rad51 and 6xHis-TCTP proteins puriﬁed
from transformed E. coli expressing Rad51 or TCTP, although we
were able to conﬁrm the association of Rad51 with TCTP in MCF-7
cells by reciprocal immunoprecipitation. Hence, we assume that
the link between HR repair processes and TCTP may be indirect.
Indeed, the fact that no obvious changes of subcellular localiza-
tion of TCTP upon NCS treatment and no nuclear TCTP foci
formation following double-strand breaks further strengthen our
assumption (Supplementary Figure S2). Furthermore, the indirect
link between TCTP and HR repair is consolidated by the
mechanisms of the TCTP-mediated regulation of proapoptotic
protein Bax and tumor suppressor TP53.21,23
We found that TCTP is required for maintaining the stability of
Rad51 in MCF-7 cells, and how TCTP affects the stability of Rad51
is unclear so far. Some hints may arise from previously published
observations. First, the binding of TCTP to MDM2 inhibits the
autoubiquitination of MDM2 and increases MDM2 level.23 Second,
Mcl-1 protein could bind to TCTP and cause stabilization of TCTP
probably via inhibition of ubiquitin-proteasome pathway.40
Consistent with these observations, a number of proteins related
to ubiquitin degradation pathway indeed appeared in our
TCTP interactome, suggesting that TCTP might involve in
ubiquitin-mediated degradation of proteins including Rad51.
Alternatively, TCTP may act as a molecular chaperone for
protecting RAD51 from degradation. TCTP itself is protected by
chaperone protein Hsp27 from misfolding and ubiquitin-
proteasome degradation.43,47 Thus, downregulation of TCTP via
gene silencing or Hsp27 dysfunction would render RAD51 more
susceptible to misfolding and protein degradation.18 In this
regard, more vigorous investigations are needed to elucidate
the underlying mechanisms.
We have demonstrated that antidepressant chemical drugs
such as sertraline can sensitize MCF-7 cells to DNA damage
treatment. However, the mechanism by which sertraline sup-
presses cell resistance to DNA damage has not been fully
understood. Previous studies suggest that the direct binding of
sertraline to TCTP protein would inhibit the association of TCTP
with MDM2;23 as a consequence, the upregulation of MDM2
autoubiquitination leads to the accumulation of TP53, which
renders the cells more prone to apoptosis upon genotoxic stress.
In addition, a low level of TCTP may result in the derepression of
dimerization of Bax, which is required for its proapoptotic activity
in cells. Alternatively, we found that inhibition of TCTP by
sertraline-sensitizing cells to DNA-damaging drug etoposide and
poly (ADP-ribose) polymerase inhibitor olaparib probably is the
consequence of the impairment of HR repair, because a certain
level of TCTP is required for efﬁcient HR processes. Towards this
point, the promotion of HR repair by TCTP is unlikely the only
factor accounting for cell resistance to DNA-damaging agents.
Consistent with a previous ﬁnding,19 the DNA ligase LIG3 and PIKK
kinase DNA-dependent protein kinase complexes revealed in our
TCTP interactome strongly suggest that the TCTP-mediated NHEJ
pathway should also contribute to the repair of DNA double-
strand breaks other than HR repair.
The fact that high levels of TCTP are associated with malignancy
progression and chemoresistance makes TCTP an intriguing target
for chemotherapy to human cancer treatment.15,23,31 It has been
shown that silencing TCTP expression by small interfering RNA
induces caspase-dependent cell death and increases the efﬁcacy
of chemotherapy in castration-resistant LNCaP cells.47 Hence, it is
plausible for exploring a chemical TCTP inhibitor in combination
with conventional chemotherapeutics to improve the effective-
ness of conventional chemotherapy for a group of human cancer
patients with high levels of TCTP expression. Our observations of
sensitization of DNA-damaging drug etoposide and poly (ADP-
ribose) polymerase inhibitor olaparib by inactivation of TCTP with
sertraline treatment also offer more clinical relevance to radiation
therapy or chemotherapy for cancer treatment. In addition to our
in vitro results, more in vivo experiments such as testing in mouse
tumor models need to be done before any clinical trials. Given the
fact that sertraline is a widely used antidepression drug and its
pharmacology is largely known,48,49 it would be plausible for us to
explore the application of sertraline or its derivatives as a new
class of TCTP targeting sensitizers for human cancer treatment in
the future.
In summary, by using afﬁnity puriﬁcation-based proteomic
proﬁling, we have identiﬁed a role of TCTP in the regulation of
DNA repair, in particular, the HR repair. The unanticipated role of
TCTP in HR processes not only sheds new insight into the
molecular mechanism underlying HR repair but also highlights the
great potential for exploiting chemical inhibitors against TCTP in
combination with conventional chemotherapy for the better
treatment of human cancers in the clinic.
MATERIALS AND METHODS
Cell lines and DNA damage treatment
Human cancer cell lines HeLa and MCF-7 were purchased from ATCC
(Manassas, VA, USA). Cells were grown under standard tissue culture
conditions (37 °C, 5% CO2) in RPMI-1640 (HeLa) containing 10% fetal
bovine serum or DMEM (MCF-7) containing 10% fetal bovine serum. For
DNA damage treatment, cells were subjected to 300 ng/ml NCS or 10 Gy of
ionizing radiation (γ-ray, generated from a Cobalt-60 source at the second
afﬁliated hospital of Harbin Medical University, Harbin, China) or 20 J/m2
UVC irradiation (UV Crosslinker; Hoefer Inc., Holliston, MA, USA).
Antibodies and chemical reagents
All chemicals including NCS, neomycin (G418), puromycin, sertraline, CHX,
MS grade water, acetonitrile and formic acid were purchased from Sigma-
Aldrich (St Louis, MO, USA). Porcine sequencing grade modiﬁed trypsin
was bought from Promega (Fitchburg, WI, USA). Etoposide was purchased
from Yeasen Biotechnology Inc. (Shanghai, China). Olaparib was purchased
from Meilunbio Inc. (Dalian, China). Antibodies against TCTP (Cell Signaling
Technology, Danvers, MA, USA, no. 7178; Santa Cruz, Dallas, TX, USA, sc-
100763), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cell Sig-
naling Technology, no. 5174), phospho-histone H2AX (Ser139) (Cell
Signaling Technology, no. 3014), Rad51 (Calbiochem, Billerica, MA, USA,
PC130; Merck Millipore, Billerica, MA, USA, 05-525), Flag M2 antibody
(Sigma-Aldrich, F1804), anti-mouse secondary antibody (Rockland, Limer-
ick, PA, USA, no. PV-9000), anti-rabbit secondary antibody (Rockland, no.
611-130-122), magnetic protein A beads (Invitrogen, Carlsbad, CA, USA)
and so on were purchased from the indicated companies, respectively. For
western blotting, antibodies were used at a dilution of 1:1000, and for
immunoﬂuorescence staining, antibodies were used at 1:400.
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Immunoprecipitation and LC-MS/MS analysis
A total of 4 × 107 HeLa cells expressing 3 × Flag-TCTP or an empty vector at
log phase were harvested by trypsin digestion and centrifugation. The cells
were washed with phosphate-buffered saline (PBS), and lysed with 2 ml
RIPA buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.25%
sodium deoxycholate, proteinase inhibitor cocktail (Roche, Basel, Switzer-
land) for 20 min at 4 °C. The lysate mixture was subjected to sonication to
completely disrupt cells. Lysates were clariﬁed by centrifugation at
14 000 r.p.m. for 30 min at 4 °C . Twenty micrograms of mouse anti-Flag
antibody and 100 μl of magnetic protein A beads were added to 2 ml of
TCTP or control lysates containing 100 mg of total proteins. Immunopre-
cipitation was performed for 4 h at 4 °C with gentle rotation. Bound
immunocomplexes on beads were washed with RIPA buffer for three times
and an aliquot of 10 μl of bead slurry was taken for western blotting. The
remaining bound proteins on the beads were eluted by boiling in 2 × SDS–
PAGE gel sample loading buffer, and resolved on a 15% SDS–PAGE gel and
stained with Coomassie blue. Gel slices were cut and digested with trypsin
at 37 °C overnight. Peptides were extracted with 50% acetonitrile, 0.1%
formic acid and dried in a speed vacuum. Each peptide sample was
desalted by stage tip50 and analyzed by LC-MS/MS on a LTQ-Orbitrap Velos
mass spectrometer (Thermo Fisher Scientiﬁc, Carlsbad, CA, USA). MS/MS
spectra were searched via the SEQUEST algorithm against a composite
database containing the Uniprot_Human database (46, 441 sequences)
and its reversed complement. Search parameters are allowed for dynamic
modiﬁcations of oxidation on Met or deamidation on Asn or Gln and up to
two missed cleavages and maximum modiﬁcations ⩽ 3 per peptide.
Matches were ﬁltered with common parameters (mass tolerance ⩽ 0.5 Da,
XCorr ⩾ 2.0) to a peptide false discovery rate o1%.51
Cloning and plasmid construction for gene expression or silencing
For TCTP cloning, total RNA was extracted from HeLa cells using TRIzol
reagent. cDNAs were synthesized by the qScript cDNA Super-Mix Kit
(Invitrogen). The coding region of TCTP (GenBank Accession No.
NM_003295) was ampliﬁed from above cDNAs by using the following
gene-speciﬁc primers: TCTP-F, 5′-GCATCTCGAGATGATTATCTACCGGGA-3′
and TCTP-R, 5′-GCATGAATTCCTAAAGATGTATTCCCCAATTC-3′ and cloned
into pcDNA3.1 (− ) 3 × Flag vector (Invitrogen) through XhoI/EcoRI
restriction sites. The correct construct was conﬁrmed by DNA sequencing.
GV102 plasmid expressing shRNA for TCTP silencing were purchased from
Genechem (Shanghai, China) containing the following TCTP targeting
sequence: 5′-ACATCCTTGCTAATTTCAA-3′ (shTCTP-1) and 5′-AGGAAAC
AAGTTTCACAAA-3′ (shTCTP-2), or 5′-CGCCTGAAGTCTCTGATTA-3′ (shFF2)
against the ﬁreﬂy luciferase gene as negative shRNA control for gene
silencing. The TCTP expression or silencing plasmids were transfected with
Lipofectamine 2000 transfection reagent (Invitrogen) into the desired cells
and transfected cell lines were selected in the presence of 200 μg/ml
hygromycin B or 2.0 μg/ml puromycin (Sigma-Aldrich), and individual cell
clones were conﬁrmed by western blotting with antibodies against the
target proteins. For bacterial expression of GST-Rad51 fusion protein, the
coding region of Rad51 (GenBank Accession No. NM_002875.4) was
ampliﬁed from above cDNAs by using the following gene-speciﬁc primers:
Rad51-F, 5′-AATGGATCCATGGCAATG-CAGATGCAGCTTG-3′ and Rad51-R,
5′-TTAGCGGCCGCTCAGTCTTTGGCATCTCCCAC-3′ and cloned into pET-41a
(+) (Novagen, Billerica, MA, USA) via BamHI and NotI sites. For bacterial
expression of 6xHis-TCTP, the following primers were used for ampliﬁca-
tion of TCTP: TCTP-His-F, 5′-GCATCTCGAGCATGATTATCTACCGGGA-3′ and
TCTP-His-R, 5′-ACTGGAATTCCTAAAGATGTATTCCCCAATTC-3′, and the
resulting TCTP gene was cloned into pBad/His A (Invitrogen) via XhoI
and EcoRI sites.
Site-directed mutagenesis
For generating shRNA-resistant TCTP mutant gene, the following primer
pairs containing desired mutations were used for site-directed mutagen-
esis of TCTP, shTCTP-1-resistant primer-F: 5′-CAGAACAAATCAAGCATCTA
GCACTGGACTTTAAAAACTACCAGTTCTT-3′ and shTCTP-1 resistant primer-R:
5′-AAGAACTGGTAGTTTTTAAAGTCCAGTGCTAGATGCTT-GATTTGTTCTG-3′.
pcDNA3.1 (− ) 3 × Flag-TCTP plasmid was used as template for high ﬁdelity
PCR and digested with DpnI restriction enzyme after PCR, the newly
synthesized TCTP mutant expression plasmid DNA was transformed into
E. coli, the desired TCTP shRNA-resistant gene was veriﬁed by DNA
sequencing.
Afﬁnity puriﬁcation of fusion protein expressed from E. coli
pET-41a (+) vector expressing GST-Rad51 or pBad/His A vector expressing
6xHis-TCTP (Invitrogen) was transformed into BL21 E. coli, the transformed
bacteria were cultured in LB medium until its optical density 600 nm
reached to 1.0. Isopropylthiogalactoside or L-arabinose (Sigma-Aldrich) was
added into the culture at a concentration of 0.2 mM and the desired
expression of protein was inducted for 8 h at 30 °C. The bacteria were
harvested by centrifugation and lysed by sonication. GST-Rad51 or 6xHis-
TCTP protein was afﬁnity puriﬁed by using glutathione or Ni-NTA magnetic
beads (Thermo Fisher Scientiﬁc). Bound proteins were eluted with solution
containing glutathione or imidazole and dialyzed against PBS buffer as the
methods described in the user manual provided by the manufacturer.
Immunoﬂuorescence for DNA damage foci formation
Cells were cultured on coverslips. After the desired DNA damage
treatment, cells were ﬁxed in 4% (wt/vol) paraformaldehyde for 10 min
at room temperature, permeabilized in 0.2% Triton X-100 in PBS for 10 min,
blocked with 4% (wt/vol) bovine serum albumin and incubated with the
primary antibodies (Rad51 or γ-H2AX) overnight and followed by
incubating with secondary goat-anti-rabbit antibodies conjugated with
FITC (Alexa Fluor 488) or Texas Red (Alexa Fluor 594) labeling (Invitrogen)
for 1 h at room temperature. Coverslips were mounted in 4′,6-diamidino-2-
phenylindole (DAPI) containing media (Vectashield, Burlingame, CA, USA).
Signals were visualized using a Leica DM500 B ﬂuorescence confocal
microscope (Wetzler, Germany). DNA damage foci were analyzed by using
the Image J software (NIH, Bethesda, MD, USA).
Homologous recombination repair assay
GFP-Pem1 reporter and HA-I-Sce I expression vectors were kindly provided
by Dr Vera Gorbunova (University of Rochester, Rochester, NY, USA). GFP-
Pem1 cassettes were stably integrated into the desired cell lines. The
resulting cell lines were transiently co-transfected with HA-I-Sce I
expression and orange ﬂuorescence protein expression vectors (Life
Technologies, Carlsbad, CA, USA), cells were harvest at various time points
post I-Sce I induction, GFP-positive cells were detected by ﬂuorescence-
assisted cell sorting (BD Biosciences, San Jose, CA, USA) and the
percentage of GFP cells was normalized to orange ﬂuorescence protein
expression cells for transfection efﬁciency control. Expression of GFP was
also monitored and recorded under ﬂuorescence microscopy (Nikon,
Eclipse Ti-S, Minato, Tokyo, Japan) at various time points.
MTT assay for cell proliferation and cytotoxicity
Cells were plated at a density of 5000 cells per well in 96-well plates at 37 °
C in 5% CO2 atmosphere. After 24 h of culture, the medium in the wells
was replaced with fresh medium containing 2.5 μM sertraline (or 0.25, 0.5,
1.0 μM etoposide) for another 24 h (1 h for etoposide, after drug removal
another 72 h culture) incubation. Then, the medium was removed and
methanethiosulfonate assay was performed according to the manual
provided by the manufacturer (Invitrogen). Absorbance at 495 nm is
directly proportional to the number of viable cells in culture. Inhibition of
cell growth was calculated as (optical density 495 nm of untreated− optical
density 495 nm of treated)/optical density 495 nm of untreated. All
measurements were performed in triplicate. The morphological pheno-
types of sertraline-treated cells were also examined under light
microscopy.
Colony formation assay
Trypsinized cells were seeded into 10 cm plates (250 cells per plate) and
cultured overnight. For etoposide sensitization experiment, etoposide
were added into each well at a ﬁnal concentration of 0.5 μM for 1 h on day
1, drugs were removed and followed by a continuous 2.5 μM sertraline
treatment for 7 days with medium change every other day. For olaparib
sensitization experiment, 0.5 μM olaparib alone or in combination with
2.5 μM sertraline were added into cells on the following day 1, and
continuously presented in the medium with medium change every other
day for 7 days. Survival cells were stained with Giemsa and colonies with
more than 50 cells were counted manually. The survival rates were
calculated as average colonies versus seeding cell numbers and normal-
ized to colonies formed from the untreated groups.
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Flow cytometry
For apoptotic cells detection, the desired cells with appropriate treatments
were harvested by trypsin digestion and washed in cold PBS buffer, and
then cells were incubated with Annexin V-FITC conjugates in PBS buffer
containing 1 mg/ml propidium iodide and 0.1 mg/ml RNase A. After
30 min incubation in dark, samples were subjected to ﬂow cytometry (BD
Biosciences). For GFP expression detection, the desired cells were
trypsinized and resuspended in PBS solution and subjected to
ﬂuorescence-assisted cell sorting.
Protein half-life measurement
Cells at log phase were seeded into 6 cm plates. After one day of culture,
50 μg/ml of CHX was added into each plate, and cells were harvested at
30 min interval for a total of 3 h period of time course. The whole-cell
lysates were prepared by adding 100 μl of 2 × SDS loading buffer to each
plate, and the lysates were collected and subjected to sonication. A total of
40 μg cell lysate of each sample were loaded and resolved on 12% SDS–
PAGE gels, an antibody against Rad51 was used for probing endogenous
Rad51. The western blot signals were quantiﬁed by densitometry scanning
and Image J analysis. The GAPDH signal was also detected and used for
normalization. The calculation of the average Rad51 half-life was based on
the signal versus time curve generated from at least three independent
CHX treatments.
Bioinformatic analysis
Gene annotation was obtained from the Uniprot_Human database, Gene
Ontology analysis was performed by the Panther Classiﬁcation System.27 A
GeneMANIA program was used for network modeling and functional
module discovery.28
Statistical analysis
For statistical evaluation, data are expressed as mean± standard deviation.
Statistical differences for comparisons of TCTP expression level and cell
growth were determined by Student’s T-test. The changes of apoptosis
and GFP cells and foci numbers were examined by the one-way analysis of
variance analysis. All analyses were performed using SPSS for Windows
13.0 software (SPSS Inc., Chicago, IL, USA). Po0.05 (two tailed) was
considered statistically signiﬁcant.
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